IRVINE, Calif.--(EON: Enhanced Online News)--Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Psychemedics Corporation (“Psychemedics” or the “Company”) (Nasdaq: PMD) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between February 28, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.
“preventing other companies from accessing (the) market.”
If you purchased shares of Psychemedics during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at firstname.lastname@example.org.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
On January 31, 2017, it was made public that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics' local representative in Brazil, will compensate Omega Laboratories, Inc. USA for losses from anticompetitive practices that are used for "preventing other companies from accessing (the) market.” When this information was released to the public, shares of Psychemedics fell, causing shareholders harm.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: 949-419-3834, or via e-mail at email@example.com.
This press release may constitute Attorney Advertising in some jurisdictions.